Literature DB >> 19779097

Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Marta Moral1, Carmen Segrelles, Ana Belén Martínez-Cruz, Corina Lorz, Mirentxu Santos, Ramón García-Escudero, Jerry Lu, Agueda Buitrago, Clotilde Costa, Cristina Saiz, José M Ariza, Marta Dueñas, Jose L Rodriguez-Peralto, Francisco J Martinez-Tello, Maria Rodriguez-Pinilla, Montserrat Sanchez-Cespedes, John Digiovanni, Jesús M Paramio.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a common human neoplasia, of poor prognosis and survival, which frequently displays Akt overactivation. Previously, we reported that mice expressing high levels of constitutively Akt activity (myrAkt) in oral epithelia develop lesions and tumors in the oral cavity.
MATERIALS AND METHODS: Functional genomics of primary keratinocytes from different transgenic mouse lines and immunostaining of mouse and human samples were performed in order to identify and validate putative biomarkers of oral cancer progression.
RESULTS: The expression of KLF4 was found to be increased only in tumor prone samples from mice bearing overactivation of Akt. Such increased expression was confirmed in oral dysplasias and tumors arising in those mice. Tissue microarray analysis of human samples confirmed the association between active Akt and increased KLF4 expression.
CONCLUSION: These data support the notion that KLF4 is potentially a reliable marker of HNSCC, and that myrAkt transgenic mice are valuable tools for preclinical research of HNSCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779097      PMCID: PMC2909848     

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  44 in total

1.  TM4: a free, open-source system for microarray data management and analysis.

Authors:  A I Saeed; V Sharov; J White; J Li; W Liang; N Bhagabati; J Braisted; M Klapa; T Currier; M Thiagarajan; A Sturn; M Snuffin; A Rezantsev; D Popov; A Ryltsov; E Kostukovich; I Borisovsky; Z Liu; A Vinsavich; V Trush; J Quackenbush
Journal:  Biotechniques       Date:  2003-02       Impact factor: 1.993

2.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

Review 3.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

4.  Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.

Authors:  Amr M Ghaleb; Beth B McConnell; Mandayam O Nandan; Jonathan P Katz; Klaus H Kaestner; Vincent W Yang
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 5.  The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology.

Authors:  Beth B McConnell; Amr M Ghaleb; Mandayam O Nandan; Vincent W Yang
Journal:  Bioessays       Date:  2007-06       Impact factor: 4.345

Review 6.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors:  Jean Bourhis; Jens Overgaard; Hélène Audry; Kian K Ang; Michele Saunders; Jacques Bernier; Jean-Claude Horiot; Aurélie Le Maître; Thomas F Pajak; Michael G Poulsen; Brian O'Sullivan; Werner Dobrowsky; Andrzej Hliniak; Krzysztof Skladowski; John H Hay; Luiz H J Pinto; Carlo Fallai; Karen K Fu; Richard Sylvester; Jean-Pierre Pignon
Journal:  Lancet       Date:  2006-09-02       Impact factor: 79.321

7.  Dynamic expression of Krüppel-like factor 4 (Klf4), a target of transcription factor AP-2alpha during murine mid-embryogenesis.

Authors:  Julia Ehlermann; Petra Pfisterer; Hubert Schorle
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2003-08

8.  Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis.

Authors:  Carmen Segrelles; Jerry Lu; Brian Hammann; Mirentxu Santos; Marta Moral; José Luis Cascallana; M Fernanda Lara; Okkyung Rho; Steve Carbajal; Jeanine Traag; Linda Beltrán; Ana Belén Martínez-Cruz; Ramón García-Escudero; Corina Lorz; Sergio Ruiz; Ana Bravo; Jesús M Paramio; John DiGiovanni
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

Authors:  Alfredo A Molinolo; Stephen M Hewitt; Panomwat Amornphimoltham; Somboon Keelawat; Samraeung Rangdaeng; Abelardo Meneses García; Ana R Raimondi; Rafael Jufe; María Itoiz; Yan Gao; Dhananjaya Saranath; George S Kaleebi; George H Yoo; Lee Leak; Ernest M Myers; Satoru Shintani; David Wong; H Davis Massey; W Andrew Yeudall; Fulvio Lonardo; John Ensley; J Silvio Gutkind
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

10.  Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy.

Authors:  A Jimeno; P Kulesza; J Wheelhouse; A Chan; X Zhang; E Kincaid; R Chen; D P Clark; A Forastiere; M Hidalgo
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

View more
  5 in total

1.  KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma.

Authors:  Francesca Zammarchi; Mariangela Morelli; Michele Menicagli; Claudio Di Cristofano; Katia Zavaglia; Alessandra Paolucci; Daniela Campani; Paolo Aretini; Ugo Boggi; Franco Mosca; Andrea Cavazzana; Luca Cartegni; Generoso Bevilacqua; Chiara Maria Mazzanti
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.

Authors:  Carmen Blanco-Aparicio; Marta Cañamero; Yolanda Cecilia; Belén Pequeño; Oliver Renner; Irene Ferrer; Amancio Carnero
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

3.  Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors.

Authors:  Yasuhiro Nagai; Hiromichi Tsuchiya; E Aaron Runkle; Peter D Young; Mei Q Ji; Larry Norton; Jeffrey A Drebin; Hongtao Zhang; Mark I Greene
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

4.  Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.

Authors:  Dazhong Liu; Pengfei Zhang; Jiaying Zhao; Lei Yang; Wei Wang
Journal:  Biomed Res Int       Date:  2021-05-19       Impact factor: 3.411

5.  Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma.

Authors:  Xiqing Li; Zhunlan Zhao; Xiaoling Zhang; Sheng Yang; Xia Lin; Xinglong Yang; Xiaolin Lin; Junwen Shi; Shengchun Wang; Wentao Zhao; Jing Li; Fei Gao; Mingyue Liu; Ning Ma; Weiren Luo; Kaitai Yao; Yan Sun; Shengjun Xiao; Dong Xiao; Junshuang Jia
Journal:  Oncotarget       Date:  2017-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.